erdafitinib,Vinflunine,Docetaxel,Pembrolizumab
janssen,pierre fabre,Merck
['erdafitinib', 'muc ,(-much)']
 erdafitinib significantly extended os in patients with advanced/muc with fgfralt after prior treatment with anti-pd-(l)1, with a median os of 1 year. hr 0.64 45.9% of g3-4 aes #asco23 
On the road! Medical Oncologist & Prof @AnkaraUni | GU cancer expert  🔬| Diversity & Equity 📢 Advocate 💫  🌍 #Oncology #GenitourinaryCancer